Cardiovascular health is shaped every day, not just during annual exams or acute events. Subtle shifts in sleep, stress, recovery, and activity patterns accumulate over time, often long before symptoms appear.

In our new white paper, Oura and Cardiovascular Health: Product, Scientific, and Clinical Insights, we examine how wearable technology can support more proactive, personalized cardiovascular care.

Download the full white paper to explore Oura validated heart health features, the latest scientific research, and clinical integration frameworks.

Reframing Cardiovascular Care

Cardiovascular disease remains the leading cause of death globally, contributing to nearly one-third of all deaths and 437 million disability-adjusted life years (DALYs) in 2023. Nearly 80% of this burden is linked to modifiable risk factors, including poor sleep, sedentary behavior, and chronic stress.

These risks often develop silently. Traditional care models, centered around episodic visits, may miss gradual deviations from baseline.

Oura supports a shift toward continuous insight by tracking key cardiovascular signals such as resting heart rate (RHR), heart rate variability (HRV), and VO₂ max, providing longitudinal context that complements traditional risk assessment.

Product Innovation: Cardiovascular Age and Beyond

Vascular aging and the Cardiovascular Age (CVA) feature from Oura are central themes.

CVA translates physiological data into a personalized snapshot of vascular health relative to chronological age, grounded in pulse wave velocity research and its clinical relevance.

Validation studies supporting core Oura metrics and proprietary measures such as Cumulative Stress are also explored.

Scientific and Clinical Advancement

The growing cardiovascular research portfolio at Oura includes:

  • Three abstracts presented at the American Heart Association Scientific Sessions (2025)

  • Contributions to Singapore’s flagship heart health research initiative, RESET

  • The GONDOR-AS randomized controlled trial which is evaluating whether Oura Advisor can provide useful exercise guidance to improve cardiorespiratory fitness and arterial stiffness

Together, these efforts reflect how Oura is advancing cardiovascular science through large-scale, real-world data.

Women’s Cardiovascular Health

Women remain underrepresented in cardiovascular research. Large-scale, anonymized datasets from Oura enable deeper investigation into sex-specific cardiovascular risk patterns, helping close historical knowledge gaps and support more tailored prevention strategies.

LEARN MORE: Oura’s Ongoing Commitment to Health Data Privacy and Security

Clinical Integration in Practice

Beyond research, the paper outlines practical frameworks for using Oura data in care settings, from remote hypertension monitoring to cardiac rehabilitation support.

By combining passive monitoring with personalized behavioral guidance, Oura bridges daily life and clinical care, supporting more individualized cardiovascular management.

Cardiovascular health will increasingly depend on continuous engagement with meaningful data, not just episodic measurement.

Download the full white paper to learn more about how Oura is advancing cardiovascular health through product innovation, scientific validation, and clinical integration.

RELATED: Advancing Human Health with Oura: Bridging Everyday Life and Clinical Care